

XLV offers exposure to the broader healthcare sector, while IBB targets biotech innovators. Here's how the two stack up on risk, returns, and diversification.

The State Street Health Care Select Sector SPDR ETF (XLV) offers significantly lower ownership costs, with an expense ratio of 0.08% compared to 0.58% for the Invesco Pharmaceuticals ETF (PJP). PJP provides concentrated exposure to 28 pharmaceutical stocks, while XLV holds 61 diversified healthcare companies.

Political volatility should stay elevated even after Democrats retake the House this November, State Street Investment Management said. Republicans are still expected to hold the Senate, leaving little room for sweeping legislation.

XLV has a significantly lower expense ratio of 0.08% compared to IXJ's 0.38%. IXJ provides broader exposure with 110 holdings across global markets, while XLV concentrates on 60 domestic S&P 500 stocks.

Trump's midterm push, election uncertainty and AI's political scrutiny could shape markets. Explore ETFs positioned for potential sector and post-election gains.

All too often, when investors look at the healthcare sector, they mostly see its value for its defensive merits. However, that view may be shortsighted and miss the broader picture in today's market.

XLE eyes fresh highs as oil rises, while XLF consolidates and XLV tests key support after breaking below a major trendline.

Health Care Select Sector SPDR Fund (NYSEARCA:XLV - Get Free Report) saw some unusual options trading activity on Tuesday. Traders acquired 33,298 put options on the stock. This represents an increase of 57% compared to the average volume of 21,265 put options. Health Care Select Sector SPDR Fund Stock Performance Shares of Health Care Select